Community acquired parapneumonic thoracic empyema: Predictors of outcome

Respirology

Volumn 4, Issue 2, 1999, Pages 173-179

  Lindstrom, Steven T ^a,b   Kolbe, John ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Community acquired; Outcome; Streptococcus milleri; Streptokinase; Thoracic empyema

Indexed keywords

ANTIBIOTIC AGENT; STREPTOKINASE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; PLEURA EMPYEMA; PRIORITY JOURNAL; PUS; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS MILLERI; THORACOCENTESIS; THORAX DRAINAGE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSALITY; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; DRAINAGE; EMPYEMA, PLEURAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; NEW ZEALAND; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STREPTOKINASE; TREATMENT OUTCOME;

EID: 0033002386     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.1999.00170.x     Document Type: Article

References (28)

1. Light RW, Giarard WM, Jenkinson SG, George RS. Parapneumonic effusions Am. J. Med. 1980; 69: 507-12.
2. Andrews NC, Parker EF, Shaw RR, Wilson NJ, Webb WR. Management of nontuberculous empyema Am. Rev. Resp. Dis. 1962; 85: 935-6.
3. Robinson LA, Moulton AL, Fleming WH, Alonso A, Galbraith TA. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas Ann. Thorac. Surg. 1994; 57: 803-14.
4. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema Chest 1996; 109: 1514-19.
5. Kelly JW, Morris MJ. Empyema thoracis: Medical aspects of evaluation and treatment. South Med. J. 1994; 87: 1103-10.
6. Moores DWO. Management of acute empyema. Chest 1992; 102: 1316-17.
7. Alfageme I, Munoz F, Pena N, Umbria S. Empyema of the thorax in adults: Etiology, microbiologic findings and management. Chest 1993; 103: 839-43.
8. Ryaa Storm HK, Krasnik M, Bang K, Frimodt-Moller N. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax 1992; 47: 821-4.
9. Landreneau RJ, Keenan RJ, Hazelrigg SR, Mack MJ, Naunheim KS. Thoracoscopy for empyema and hemothorax. Chest 1995; 109: 18-24.
10. Cham CW, Hag SM, Rahamim J. Empyema thoracis: A problem with late referral? Thorax 1993; 48: 925-7.
11. Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994; 105: 832-6.
12. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108: 299-301.
13. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev. Infect. Dis. 1988; 10: 257-85.
14. Murray HW, Gross KG, Masur H et al. Serious infections caused by Streptococcus milleri. Am. J. Med. 1978; 64: 759-64.
15. Molina JM, Leport C, Bure A et al. Clinical and bacterial features of infections caused by Streptococcus milleri. Scand. J. Infect. Dis. 1991; 23: 659-66.
16. Wong CA, Donald F, MacFarlane JT. Streptococcus milleri pulmonary disease: A review and clinical description of 25 patients. Thorax 1995; 50: 1093-6.
17. Frankish PD, Kolbe J. Thoracic empyema due to Streptococcus milleri: Four cases. NZ Med. J. 1984; 97: 849-51.
18. Muers MF. Streptokinase for empyema Lancet 1997; 349: 1491-2.
19. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality Chest 1991; 99: 1162-5.
20. Bouros D, Schiza S, Patsourakis G et al. Intrapleural Streptokinase versus Urokinase in the treatment of complicated parapneumonic effusions: A prospective, double-blind study. Am. J. Respir. Crit. Care Med. 1997; 155: 291-5.
21. Taylor RFM, Rubens MB, Pearson MC, Barnes NC. Intrapleural Streptokinase in the management of empyema. Thorax 1994; 49: 856-9.
22. Willsie-Ediger SK, Salzman G, Reisz G, Foreman MG. Use of Intrapleural Streptokinase in the treatment of thoracic empyema. Am. J. Med. Sci. 1990; 300: 296-300.
23. Pollak JS, Passik CS. Intrapleural Urokinase in the treatment of loculated pleural effusions. Chest 1994; 105: 868-73.
24. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary Urokinase. Chest 1995; 108: 1252-9.
25. Chin NK, Lim TK. Controlled trial of intrapleural strep-tokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-9.
26. Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of Streptokinase. Effects on systemic fibrinolysis. Thor. Cardiovasc. Surg. 1981; 29: 124-6.
27. Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest 1989; 95: 945-6.
28. Odell JA. Management of empyema thoracis. J. Royal Soc. Med. 1994; 87: 466-70.